Research on infections caused by bacteria and how to fight them. Covers antibiotic resistance, biofilms, congenital syphilis, Lyme disease, and precise treatments.
Jennifer Juarez, a UTHealth doctoral student, has been awarded two research fellowships to study the spread of E. coli, a hard-to-treat bacterium that can lead to food poisoning and fatal disease. Her research focuses on understanding how bacterial cells divide and proliferate, paving the way for novel antibacterial treatments.
A study published in mBio reveals that the 2009 H1N1 pandemic flu virus causes more extensive damage to lung tissues than seasonal flu, making it more susceptible to bacterial infections like pneumonia. This damage compromises the protective epithelial cells, allowing bacteria to thrive and increase mortality.
A new compound has been developed to treat C diff infections, showing promise in killing and preventing the bacterium. The compound, MGB BP-3, is more effective than vancomycin in treating C diff and offers a potential solution for life-threatening infections.
Researchers at the University of Sheffield have created a new technology that detects bacterial infections in wounds using ultra-violet light. The polymers, attached to antibiotics, bind to bacteria and fluoresce, alerting clinicians to the severity of infection and guiding antibiotic treatment.
Researchers are working with major UK retailers to reduce bacterial infections in chickens and lower food poisoning cases. The study focuses on improving chicken welfare to combat Campylobacter infection, a leading cause of food poisoning.
Jörn Coers is honored by the American Society for Microbiology for his work on immune responses against intracellular pathogens. His research focuses on host-pathogen interactions and has revealed key insights into diseases caused by Chlamydia.
Benjamin P. Howden, a leading expert in S. aureus and E. faecium research, receives the award for his groundbreaking work on antimicrobial resistance mechanisms and virulence. His research has led to new insights into vancomycin-intermediate S. aureus and reduced linezolid susceptibility.
A team of researchers from University of Houston and St. Luke's Episcopal Hospital are working to develop improved screening methods for detecting drug-resistant superbugs, specifically carbapenem-resistant Klebsiella pneumoniae (CRKP). The bacteria can cause deadly infections in people with weakened immune systems.
Researchers analyzed the genome of a superbug called vancomycin-resistant enterococci (VRE) to understand its resistance to antibiotics. They identified changes in genes that led to daptomycin resistance, offering insights into developing new drugs to combat this growing health threat.
Researchers found that children with malaria are more susceptible to bacteraemia due to the infection itself, not a natural protection from the sickle cell gene. Malaria prevention strategies may also reduce invasive bacterial infections, with an estimated 50% of cases in endemic areas attributed to Plasmodium falciparum.
Researchers developed a genetically modified Mycobacterium smegmatis vaccine that induces strong immune response in mice, protecting them from TB infection. The vaccine effectively lowers TB bacteria levels by 1,000 times compared to the current BCG vaccine.
The Massachusetts Eye and Ear Infirmary has received a $11 million grant from the National Institute of Allergy and Infectious Disease to coordinate a Harvard-wide project on antibiotic resistance. The goal is to develop new antibiotics to treat highly resistant infections caused by staph and other related bacteria.
Research reveals that Helicobacter pylori causes DNA breaks in gastric mucosa cells, triggering genetic mutations and cell death. The study's findings suggest that prolonged infections can lead to exhaustion of the cell's repair response, exacerbating gastric carcinogenesis.
A potential vaccine against tuberculosis has been found to completely eliminate the disease-causing bacteria from infected tissues in mice. The vaccine uses a modified strain of bacteria that triggers a specific immune response, providing longer protection and bactericidal immunity.
A new study found that plerixafor, a drug already approved for bone marrow transplants, corrects panleukopenia in patients with WHIM syndrome. This targeted therapy may provide a more effective treatment for this rare immune deficiency.
Researchers have devised a novel strategy for developing rapid, inexpensive diagnostic tests for microbial infections by identifying soluble microbial antigens. The InMAD system successfully identified antigens for biothreats Burkholderia pseudomallei and Francisella tularensis.
A study published in the American Journal of Infection Control found that over 60% of hospital nurses' and doctors' uniforms tested positive for potentially dangerous bacteria. The study, led by Yonit Wiener-Well, MD, revealed a prevalence of antibiotic-resistant strains in close proximity to hospitalized patients.
A Johns Hopkins Children's Center study of over 3,000 hospitalized children reveals that those colonized with MRSA but not sick are at significant risk for developing full-blown infections. The study found nearly six times more likelihood of invasive MRSA infections among carriers compared to noncarriers.
Drs. Peter Cadieux and Hassan Razvi have been awarded a $566,000 grant as part of a $2.2 million initiative to explore novel coatings that significantly reduce bacterial adherence to urinary tract stents and catheters. The research aims to improve prevention and treatment of urinary device-associated infections.
Researchers at the University of Bristol have developed a novel approach for studying molecules within their natural environment, allowing for unprecedented detail on bacterial infection mechanisms. The breakthrough utilizes a lateral molecular force microscope to measure biological phenomena directly on a living cell surface, enabling...
Research reveals that E. coli O157 can persist in the environment for over 15 weeks, making it essential for everyone to take precautions when visiting rural areas or consuming contaminated food and water. Farmers, visitors, and governments must adopt strategies to reduce risks and promote awareness about the dangers of this bacteria.
Researchers at Scripps Research Institute successfully designed a new antibiotic that can target and kill the most resistant bacterial infections. The compound, an analogue of vancomycin, overcomes the resistance mechanism by altering the key atom in the peptidoglycan structure.
A common bacterium, Wolbachia, has been found to prevent the Aedes aegypti mosquito from transmitting the dengue virus, a major public health threat. The discovery offers a promising alternative to current control methods and could have a transformative effect on global health.
Researchers have successfully controlled Dengue fever in northern Australia by releasing Wolbachia-infected mosquitoes, which suppress the virus and prevent transmission. The study demonstrates a promising approach to eliminating this disease, with potential applications in other regions.
Researchers at the Trudeau Institute have discovered that FluMist elicits protection by inducing a very early non-specific immune response in the lungs, which is protective against both matching and non-matching influenza strains. This response also limits lung inflammation and reduces susceptibility to secondary bacterial infections.
Researchers found that coriander oil damages bacterial cell membranes, inhibiting essential processes and ultimately killing bacteria. The study suggests using coriander oil as a natural alternative to common antibiotics for treating food-borne illnesses and multidrug-resistant infections.
A study found that Afghan patients at a US military hospital in Afghanistan carry multidrug-resistant bacteria, posing a risk to both local and foreign patients. The high rate of MDR bacteria among Afghans is partly due to longer hospital stays.
Scientists have successfully tuned bacteriophage endolysins to increase their effectiveness against C. difficile, a common cause of hospital-acquired infections. The study proposes using truncated versions of these natural antimicrobials as a new weapon in the battle against superbugs.
Researchers have identified a key mechanism used by intestinal cells to defend against Clostridium difficile infections. A previously unknown protective response, known as nitrosylation, can be exploited to prevent toxin-induced cell damage.
A novel imaging probe has been developed to detect dangerous heart-valve infections, such as those caused by Staphylococcus aureus, noninvasively. The probe uses a radiolabeled version of prothrombin to reveal the presence of infected bacteria in mouse models.
A natural defense mechanism has been uncovered that inactivates the toxin spreading C. diff by binding to it with S-nitrosoglutathione (GSNO), a NO-based molecule. This finding provides a basis for developing new therapies targeting toxins directly.
Researchers identify a molecular process by which human cells can neutralize toxins released by Clostridium difficile, offering a promising new treatment for intestinal disease. The discovery could also be applied to other bacterial diseases and has the potential to revolutionize the treatment of hospital-acquired infections.
A new study found that a combination of minocycline and EDTA can prevent bacterial infections in dialysis patients using catheters, improving patient outcomes. The treatment reduced the risk of infection by half compared to traditional heparin use.
Scientists describe how a multipurpose protein on a virus tail bores into bacteria like a drill bit and clears debris. The 'Swiss Army Knife' protein enables the virus to pump its genetic material into bacteria, infecting them.
The number of hospitalizations for skin and soft-tissue infections, primarily caused by community-acquired Methicillin-resistant Staphylococcus aureus (MRSA), has more than doubled since 2000. Early treatment and recognition are crucial to preventing hospitalization.
A recent investigation found that a common strain of C. difficile, known as BI/NAP1, is endemic in Chicago-area acute care hospitals, putting patients at risk for severe disease. The outbreak strain was spread through patient transfers between healthcare facilities.
A new study suggests that moderate exercise can prevent age-related memory loss after a bacterial infection. Researchers found that older rats who ran on an exercise wheel showed improved cognitive function and reduced inflammation in the hippocampus compared to non-exercising rats.
A small amount of exercise has been shown to prevent exaggerated inflammation in the brain and long-lasting memory impairments following a bacterial infection. This study suggests that voluntary exercise can confer robust benefits for those who exercised, especially for older adults at risk of memory loss.
The World Health Organization has released updated guidelines for managing drug-resistant tuberculosis, highlighting the need for more research to improve disease management. Key recommendations include wider use of rapid drug susceptibility testing and ambulatory models of care.
Charles Darkoh, a UTHealth graduate student, has been awarded a prestigious UNCF/Merck fellowship to conduct research on multidrug-resistant Clostridium difficile bacterial infection. His work aims to develop a cost-efficient diagnostic test and novel therapeutic strategies for C. difficile infection.
Researchers found that individuals lacking TLR1 proteins are more susceptible to tuberculosis, leading to decreased immune function. The study suggests a potential approach for personalized therapy and prioritizing drug treatment in developing countries.
Researchers found that intravenous fluids can lower the odds of developing severe kidney failure in children infected with E. coli O157:H7, a common cause of pediatric kidney failure. The study suggests that early fluid administration may protect kidneys and reduce the need for dialysis.
A bacterial outbreak of Burholderia cepacia complex was linked to contaminated nasal spray products, leading to a national recall. The investigation highlighted the need for improved testing protocols in the production and distribution of over-the-counter pharmaceuticals.
Bacteria Pseudomonas aeruginosa uses a toxin delivery system called Type VI secretion system (T6SS) to break down rival bacteria's protective barriers. The mechanism also helps the bacterium protect itself from its own toxins, making it a major public health concern.
Researchers at Duke University Medical Center have developed a molecule that blocks the damaging actions of Chlamydia by disarming its self-defense mechanisms. The therapy will disarm CPAF, a central weapon of Chlamydia, allowing the body to take care of the rest and ultimately lead to the death of the infected cell and the bacteria.
Researchers developed maltodextrin-based imaging probes that can detect bacterial infections in animals with high sensitivity and specificity. These probes distinguish bacterial infections from other inflammatory conditions, such as cancer, and can detect as few as one million viable bacteria cells.
Researchers have identified genetic similarities between Streptococcus pyogenes and Streptococcus equi, two bacteria that cause potentially fatal infections in humans and horses. The study suggests a shared strategy for causing disease and offers hope for developing novel vaccines for both species.
Researchers discovered a new enzyme called SidD used by Legionella pneumophila to control its host cell and replicate. This finding provides insight into bacterial infection mechanisms and could lead to the design of a new therapy to save lives.
Researchers found that early infection with H. pylori bacteria impairs immune system maturation and triggers the accumulation of regulatory T-cells that suppress asthma. Mice infected at an early age enjoyed effective protection, but lost resistance if antibiotics were used later.
Scientists use a novel technique to analyze virus-bacterium associations in living organisms, revealing one-to-one correspondence and potential ancient infections. The study opens new avenues for understanding coevolution between viruses and their hosts.
A new rapid test can accurately diagnose bacterial and viral infections, allowing for timely treatment. The test exploits differences in immune system responses to distinguish between the two types of infections.
Rensselaer Polytechnic Institute engineer Cynthia Collins will study the effects of microgravity on Pseudomonas aeruginosa and Staphylococcus aureus bacteria aboard the Space Shuttle Atlantis. The research aims to understand how biofilms form in space, which could help protect astronauts from infections.
A study by Cedars-Sinai surgeon Shirin Towfigh found that daily probing of wounds with a dry cotton swab after surgery dramatically reduced infections in post-operative incision sites. The technique resulted in significantly shorter hospital stays and better cosmetic healing.
Researchers at the University of Rochester Medical Center identified a collagen-binding protein allowing Streptococcus mutans to invade heart tissue, causing endocarditis. The discovery may lead to a screening tool to gauge dental patients' vulnerability.
A meta-analysis of bacterial-virus interactions reveals a nested structure, with hard-to-infect bacteria infected by generalist viruses and easy-to-infect bacteria attacked by both generalist and specialist viruses. This discovery could improve predictions of microbial population dynamics and community assembly.
A study found that infection with influenza likely increases the incidence of invasive pneumococcal disease (IPD). Influenza infection may increase the short-term risk of bacterial invasion in individuals already colonized with Streptococcus pneumoniae, which causes IPD. This suggests that some cases of IPD could be attributable to inf...
Researchers have identified a new target for combating cystitis: the thread-like structures on E. coli bacteria that adhere to bladder cells. Understanding this mechanism can lead to the development of new antibiotics, offering hope for treating recurring urinary tract infections.
The majority of potential patients are eager for fecal microbiota transplantation to become available, despite concerns about donor selection and screening. Patients view the treatment as 'natural' and easier than currently available therapies.
Researchers at University College London and Birkbeck have discovered the structure of FimD, a protein complex that assembles pili on cystitis bacteria. This breakthrough provides insights into pilus biogenesis and has potential applications in developing new antibiotics that target cystitis.
Scientists have discovered how bacteria produce and secrete pili, which help them attach to human cells and cause infection. The research provides new insights into the mechanism of pilus formation and suggests potential targets for antibacterial drugs.